Measurement of CRP during hospitalization for STEMI and at one month after discharge can aid in identifying patients who are most likely to benefit from early implementation of anti-inflammatory strategies for preventing HF in long-term follow-up. The gene discussed is CRP; the disease is hydrops fetalis.